Advertisement

PharmacoEconomics & Outcomes News

, Volume 817, Issue 1, pp 20–20 | Cite as

Ixekizumab cost effective versus secukinumab for plaque psoriasis

Clinical study
  • 3 Downloads

Reference

  1. Johannson E, et al. Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain. ClinicoEconomics and Outcomes Research 2018: 747-759, No. 10, 12 Nov 2018. Available from: URL: https://doi.org/10.2147/CEOR.S167727 CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations